文献速递哮喘

成人哮喘DNA甲基化全表观基因组关联研究:非特应性与特应性哮喘的差异甲基化位点

Epigenome-wide association study of DNA methylation and adult asthma in the Agricultural Lung Health Study.
PubMed 文献 · Eur Respir J · 2020-09-03

在美国农业队列中嵌套的病例对照研究(2286人)中,采用Illumina MethylationEPIC芯片检测血液DNA甲基化,比较非特应性哮喘、特应性哮喘、单纯特应性及参照组。发现非特应性哮喘有8个CpG位点达FWER显著性(p<9×10-8)、524个达FDR<0.05,涉及382个新基因;特应性哮喘有181个FWER、1086个FDR位点,涉及569个新基因,104个FDR位点重叠。非特应性哮喘35%、特应性哮喘91%的CpG位点在血液、嗜酸性粒细胞、气道上皮或鼻上皮研究中重复。

要点

  • 非特应性哮喘和特应性哮喘均存在大量差异甲基化CpG位点,但位点谱不同。
  • 特应性哮喘的差异甲基化位点数多于非特应性哮喘,且重复率更高。
  • 血液甲基化标志物部分在哮喘相关组织中重复,涉及神经与炎症通路。

核心结论

  • 非特应性和特应性哮喘均存在众多不同的差异甲基化CpG位点,血液标志物部分在哮喘相关组织中重复。

研究设计与样本

  • 美国农业队列中嵌套的成人当前哮喘病例对照研究,共2286名参与者,使用Illumina MethylationEPIC芯片检测血液DNA甲基化。
  • 参与者分为单纯特应性(n=185)、非特应性哮喘(n=673)、特应性哮喘(n=271)及既无特应性也无哮喘的参照组(n=1157),采用逻辑回归分析。

主要发现

  • 单纯特应性未观察到与甲基化的关联。
  • 非特应性哮喘有8个CpG位点达FWER显著性(p<9×10-8),524个达FDR<0.05,涉及382个新基因。
  • 特应性哮喘有181个CpG位点达FWER显著性,1086个达FDR<0.05,涉及569个新基因;104个FDR位点重叠。
  • 非特应性哮喘35%、特应性哮喘91%的CpG位点在血液、嗜酸性粒细胞、气道上皮或鼻上皮研究中重复。
  • 涉及基因富集于神经系统或炎症相关通路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Epigenome-wide studies of methylation in children support a role for epigenetic mechanisms in asthma; however, studies in adults are rare and few have examined non-atopic asthma. We conducted the largest epigenome-wide association study (EWAS) of blood DNA methylation in adults in relation to non-atopic and atopic asthma.We measured DNA methylation in blood using the Illumina MethylationEPIC array among 2286 participants in a case-control study of current adult asthma nested within a United States agricultural cohort. Atopy was defined by serum specific immunoglobulin E (IgE). Participants were categorised as atopy without asthma (n=185), non-atopic asthma (n=673), atopic asthma (n=271), or a reference group of neither atopy nor asthma (n=1157). Analyses were conducted using logistic regression.No associations were observed with atopy without asthma. Numerous cytosine-phosphate-guanine (CpG) sites were differentially methylated in non-atopic asthma (eight at family-wise error rate (FWER) p<9×10-8, 524 at false discovery rate (FDR) less than 0.05) and implicated 382 novel genes. More CpG sites were identified in atopic asthma (181 at FWER, 1086 at FDR) and implicated 569 novel genes. 104 FDR CpG sites overlapped. 35% of CpG sites in non-atopic asthma and 91% in atopic asthma replicated in studies of whole blood, eosinophils, airway epithelium, or nasal epithelium. Implicated genes were enriched in pathways related to the nervous system or inflammation.We identified numerous, distinct differentially methylated CpG sites in non-atopic and atopic asthma. Many CpG sites from blood replicated in asthma-relevant tissues. These circulating biomarkers reflect risk and sequelae of disease, as well as implicate novel genes associated with non-atopic and atopic asthma.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Hoang TT, Sikdar S, Xu CJ, et al. Epigenome-wide association study of DNA methylation and adult asthma in the Agricultural Lung Health Study. Eur Respir J. 2020. PMID: 32381493. doi:10.1183/13993003.00217-2020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。